Low-dose rhEPO may reap neuroprotective benefits for preterm infants

Clarification of the dose and duration at which to give recombinant human erythropoietin to preterm infants may be key to realising its neuroprotective properties.

Source: MedWire News - May 24, 2016 Category: Consumer Health News Tags: Neurology Source Type: news